In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IP And Access Can Co-exist: Indian Pharma Alliance

This article was originally published in PharmAsia News

Executive Summary

An out-of-the-box deal has raised hopes that multinational companies and Indian generic makers can work in tandem for better access to medicines. That’s the essence of Gilead’s multiple partnering deals in India as described by the Indian Pharmaceutical Alliance – a lobby that has resisted pressures from MNCs seeking a tighter intellectual property framework in India.

Advertisement
Advertisement

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC088785

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel